TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
DRIO

DarioHealth Corp

Healthcare · Health Information Services

6.70$ +1.2% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns DarioHealth Corp (DRIO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.7% of the shares are freely tradable; institutional investors hold 9.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 9.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 77.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 10Mio.

Largest Shareholders

Institutions

Institutions DRIO
Name Stake (%) Shares Change (%) Date
Nantahala Capital Management, LLC 6.23 610,690 +8.4 03/31/2026
Vanguard Capital Management, LLC 0.67 65,910 +0.0 03/31/2026
Geode Capital Management, LLC 0.63 61,878 +24.8 03/31/2026
Vanguard Fiduciary Trust Co 0.31 30,070 +0.0 03/31/2026
Citadel Advisors Llc 0.25 24,289 +18.7 06/30/2026
BlackRock Inc 0.19 18,818 +0.0 03/31/2026
UBS Group AG 0.16 15,901 +6,390.2 03/31/2026
Northern Trust Corp 0.14 13,237 +0.0 03/31/2026

Funds

Funds DRIO
Name Stake (%) Shares Change (%) Date
Fidelity Extended Market Index 0.33 32,253 -0.2 07/31/2026
iShares Micro-Cap ETF 0.20 19,940 -1.9 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?